BRIEF published on 12/17/2025 at 11:02, 1 day 14 hours ago Valerio Therapeutics Welcomes Professor Eric Vivier to its Board of Directors Board Of Directors Oncology Immunology Valerio Therapeutics Eric Vivier
BRIEF published on 12/17/2025 at 11:02, 1 day 14 hours ago Valerio Therapeutics Accueille le Professeur Eric Vivier au Conseil d'Administration Conseil D'administration Oncologie Valerio Therapeutics Immunologie Eric Vivier
BRIEF published on 12/17/2025 at 11:02, 1 day 14 hours ago Valerio Therapeutics nomme le professeur Eric Vivier observateur au conseil d'administration Conseil D'administration Valerio Thérapeutique Immunologie Professeur Eric Vivier Stratégie En Oncologie
BRIEF published on 12/17/2025 at 11:02, 1 day 14 hours ago Valerio Therapeutics Appoints Professor Eric Vivier as Board Observer Board Of Directors Immunology Valerio Therapeutics Professor Eric Vivier Oncology Strategy
PRESS RELEASE published on 12/17/2025 at 10:57, 1 day 15 hours ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce la désignation du Professeur Eric Vivier en qualité d'Observateur de son Conseil d’Administration. Le Professeur apportera son expertise en immunologie pour développer des traitements innovants en oncologie Conseil D'administration Valerio Therapeutics Immunologie Professeur Eric Vivier Observateur
PRESS RELEASE published on 12/17/2025 at 10:57, 1 day 15 hours ago Inside Information / Other news releases Valerio Therapeutics appoints Prof. Eric Vivier as Observer to Board of Directors. Prof. Vivier, a renowned immunologist, will bring over 30 years of experience to drive innovative tumor treatment approaches Board Of Directors Valerio Therapeutics Professor Eric Vivier Immunologist Tumor Treatment
PRESS RELEASE published on 10/30/2025 at 09:04, 1 month 19 days ago Rapport financier semestriel 2025
BRIEF published on 10/30/2025 at 09:03, 1 month 19 days ago Bilan financier et stratégique de Valerio Therapeutics pour le 1er semestre 2025 Recentrage Stratégique Valerio Therapeutics Résultats Financiers 2025 Plateformes V-Body Recherche Partenariats
BRIEF published on 10/30/2025 at 09:03, 1 month 19 days ago Valerio Therapeutics' financial and strategic review for the first half of 2025 Strategic Refocusing Valerio Therapeutics 2025 Financial Results V-Body Platforms Seeking Partnerships
Published on 12/19/2025 at 01:10, 50 minutes ago Ostrom Climate Exits Existing UPRIIS ERPA Arrangements
Published on 12/19/2025 at 01:00, 1 hour ago Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited
Published on 12/19/2025 at 00:50, 1 hour 10 minutes ago High Resolution Gravity Survey Targets Challenger Repeats
Published on 12/19/2025 at 00:00, 2 hours ago LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
Published on 12/18/2025 at 23:10, 2 hours 50 minutes ago Air T, Inc. Announces Closing of Regional Express Acquisition
Published on 12/18/2025 at 22:05, 3 hours 55 minutes ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology
Published on 12/18/2025 at 22:05, 3 hours 55 minutes ago Abivax to be Added to Nasdaq Biotechnology Index
Published on 12/18/2025 at 20:09, 5 hours 51 minutes ago EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond
Published on 12/18/2025 at 19:30, 6 hours 30 minutes ago Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT
Published on 12/18/2025 at 19:30, 6 hours 30 minutes ago Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST
Published on 12/18/2025 at 18:30, 7 hours 30 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 18:30, 7 hours 30 minutes ago Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde
Published on 12/18/2025 at 17:45, 8 hours 15 minutes ago Cie du Bois Sauvage: Vernietiging eigen aandelen
Published on 12/18/2025 at 17:45, 8 hours 15 minutes ago Damartex réaffirme son éligibilité au PEA-PME
Published on 12/18/2025 at 17:45, 8 hours 15 minutes ago Cie du Bois Sauvage : Cancellation of own shares
